UPS
41
-4
HCP
58
4
SYF
85
2
PCG
93
2
ZBH
60
-2
TGT
25
-24
IVZ
46
3
IR
63
3
EQT
59
2
INTU
51
2
LB
34
8
C
58
-2
CSCO
63
2
COF
55
-3
HRL
39
15
MTCH
37
7
FOXA
55
9
BMY
53
-7
VTR
49
-3
CL
56
5
UPS
41
-4
HCP
58
4
SYF
85
2
PCG
93
2
ZBH
60
-2
TGT
25
-24
IVZ
46
3
IR
63
3
EQT
59
2
INTU
51
2
LB
34
8
C
58
-2
CSCO
63
2
COF
55
-3
HRL
39
15
MTCH
37
7
FOXA
55
9
BMY
53
-7
VTR
49
-3
CL
56
5
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
42

BIO
Bio-Rad Laboratories

Last Price:
324.90
Seasonality Move:
7.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $99.97M
Price / Cash Flow: 39.78
Annual Sales: $267.46
Price / Book: 1.17

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.69M
Gross Margin: $1.43B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 27.3

BIO Technical Analysis vs Fundamental Analysis

Sell
42
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?